aspr

FDA, ASPR Announce Shelf-life Extension for Bamlanivimab when Administered Together with Etesevimab

Child receiving oxygen with the words "pediatric covid-19 data challenge"

BARDA, HHS Partners Launch Data Challenge Competition to Develop Algorithms to Help Healthcare Providers Predict Which Children are at Risk for Severe COVID-19

The Biomedical Applied Research and Development Authority (BARDA) – in collaboration with the National Institute of Health and the Health Resources and Services Administration – launched a data challenge competition to develop algorithms (computational models) that could help healthcare providers predict which of their pediatric patients with COVID-19 are likely to develop severe COVID-19 complications, including conditions such as multisystem inflammatory syndrome in children (MIS-C). Challenge participants must develop, train, and validate computational models to predict pediatric patients at risk for hospitalization, need for ventilation, and cardiovascular interventions. Winners will receive a cash prize and may be eligible to apply for follow on funding support and in-kind services.

Submit Your Entry!
close up view of COVID-19  molecule
FDA Approves the First COVID-19
Vaccine: The Pfizer-BioNTech
COVID-19 Vaccine Will Be Marketed
as Comirnaty for the Prevention of
Disease in those 16 Years and Older
Read Release
close up shot of an infusion bag with nurse in background preparing to infuse a patient
FDA, ASPR Announce
Shelf-life Extension for
Bamlanivimab when Administered
Together with Etesevimab

Read Message
nurse taping IV to patient's hand
Check Out Our COVID-19
Monoclonal Antibody Therapeutics
Communications Toolkit:
Help Spread the Word on How to
Keep People Out of Hospitals
Download Toolkit
thousands of letters on a computer screen
BARDA Now Accepting
Submissions to Expand Existing
Next-generation Sequencing-based
Assays to Detect Respiratory
RNA Viral Pathogens
Read Announcement
People working together in conference room with the words "Application due September 20, 2021"
ASPR Announces New Notice of
Funding Opportunity for a Fourth
Regional Disaster Health Response
System Demonstration Site
Learn More
COVID-19 molecule
Phase 3 Clinical Trial Supported by
BARDA Shows Long-acting Antibody
Combination from AstraZeneca Can
Prevent Symptomatic COVID-19
Learn More
older women in hospital getting a temperature check
BARDA, Venatorx Partner to Evaluate
Drug as a Treatment for Patients with Hospital-acquired and Ventilator-
associated Bacterial Pneumonia
Read Web Announcement
Scientist in full PPE with words "Join Our Team"
BARDA Hiring Engineers with
Expertise in Pharmaceutical
Manufacturing or Medical Device
Product Development & Manufacturing
Join Our Team
male child in hospital bed having his blood pressure check
New Resources for COVID-19
Highlight Considerations Related to
Pediatric Surge Capacity, Capability,
Management, and Guidance
Download Resources
Monoclonal antibody therapy referral
New Resource Now Available: A
Sample Statewide/Regional Prototype
of a Standing Physician’s Order for
Monoclonal Antibody Treatment
Download Resource